William Hinshaw Founder of Fore Biotherapeutics Backed byHBM Healthcare InvestmentsSR OneWellington ManagementAndreas WickiSimeon GeorgeVan Jones LinkedIn SourcesFORE Biotherapeutics Raises $38 Million in Series D-2 Financing for the Continued Advancement of Plixorafenib — 2025-05 Browse all founders · Browse investors
